產(chǎn)品詳情
簡單介紹：
Anti-C17ORF39抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C17ORF39抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C17ORF39
Cat. Number:
Anti-C17ORF39抗體KL-9839R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
C17orf39 is a 300 amino acid protein that is encoded by a gene mapping to human chromosome 17. Chromosome 17 makes up over 2.5% of the human genome with about 81 million bases encoding over 1,200 genes. Two Anti-C17ORF39抗體key tumor suppressor genes are associated with chromosome 17, namely, p53 and BRCA1. Tumor suppressor p53 is necessary for maintenance of cellular genetic integrity by moderating cell fate through DNA repair versus cell death. Malfunction or loss of p53 expression is associated with malignant cell growth and Li-Fraumeni syndrome. Like p53, BRCA1 is directly involved in DNA repair, specifically it is recognized as a genetic determinant of early onset breast cancer and predisposition to cancers of the ovary, colon, prostate gland and fallopian tubes. Chromosome 17 is also linked to neurofibromatosis, a condition characterized by neural and epidermal lesions, and dysregulated Schwann cell growth. Alexander disease, Birt-Hogg-Dube syndrome and Canavan disease are also associated with chromosome 17.
Also known as:
Uncharacterized protein Anti-C17ORF39抗體C17orf39; Chromosome 17 open reading frame 39; Hypothetical protein LOC79018; MGC3048; GID4_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C17ORF39.
●
Predicted Molecular Weight: 34kDa.
Storage:
Shipped at 4℃, StoreAnti-C17ORF39抗體 at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-C17ORF39抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C17ORF39抗體dilutions must be determined by the end user.
kl135Hu02 防御素α3(DEFα3)多克隆抗體 Polyclonal Antibody to Defensin Alpha 3, Neutrophil Specific (DEFa3)
kl557Ra02 線粒體解偶聯(lián)蛋白1(UCP1)多克隆抗體 Polyclonal Antibody to Uncoupling Protein 1, Mitochondrial (UCP1)
kl541Mu02 腦鈉素(BNP)多克隆抗體 Polyclonal Antibody to Brain Natriuretic Peptide (BNP)
kl204Ra01 生長停滯特異性蛋白6(GAS6)多克隆抗體 Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
kl204Ra02 生長停滯特異性蛋白6(GAS6)多克隆抗體 Polyclonal Antibody to Growth Arrest Specific Protein 6 (GAS6)
kl087Rb21 單核細(xì)胞趨化蛋白1(MCP1)多克隆抗體 Polyclonal Antibody to Monocyte Chemotactic Protein 1 (MCP1)
kl262Mu01 整合素β3(ITGβ3)多克隆抗體 Polyclonal Antibody to Integrin Beta 3 (ITGb3)
kl033Gu01 干擾素α(IFNα)多克隆抗體 Polyclonal Antibody to Interferon Alpha (IFNa)
kl238Po01 酪氨酸酶(TYR)多克隆抗體 Polyclonal Antibody to Tyrosinase (TYR)
kl815Ra03 神經(jīng)型一氧化氮合酶(NOS1)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 1, Neuronal (NOS1)
kl099Ra01 CD8a分子(CD8a)多克隆抗體 Polyclonal Antibody to Cluster Of Differentiation 8a (CD8a)
kl331Mu01 套膜蛋白(iNV)多克隆抗體 Polyclonal Antibody to Involucrin (iNV)
kl975Ra03 肌腱蛋白C(TNC)多克隆抗體 Polyclonal Antibody to Tenascin C (TNC)
kl166Bo01 Ⅱ類主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl166Ca01 Ⅱ類主要組織相容性復(fù)合體DRα(MHCDRα)多克隆抗體 Polyclonal Antibody to Major Histocomklibility Complex Class II DR Alpha (MHCDRa)
kl463Mu02 內(nèi)皮細(xì)胞特異分子1(ESM1)多克隆抗體 Polyclonal Antibody to Endothelial Cell Specific Molecule 1 (ESM1)
kl427Hu01 肌球蛋白輕鏈4(MYL4)多克隆抗體 Polyclonal Antibody to Myosin Light Chain 4, Alkali, Atrial, Embryonic (MYL4)
